Two Sigma Advisers’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,100
Closed -$74.3K 930
2025
Q4
$74.3K Sell
31,100
-103,100
-77% -$282K ﹤0.01% 2256
2025
Q3
$382K Buy
134,200
+93,500
+230% +$320K ﹤0.01% 1882
2025
Q2
$153K Buy
40,700
+25,900
+175% +$102K ﹤0.01% 2161
2025
Q1
$67K Sell
14,800
-14,900
-50% -$78.8K ﹤0.01% 2290
2024
Q4
$210K Buy
29,700
+12,500
+73% +$99.6K ﹤0.01% 2111
2024
Q3
$140K Sell
17,200
-28,800
-63% -$208K ﹤0.01% 2128
2024
Q2
$294K Sell
46,000
-124,500
-73% -$799K ﹤0.01% 2073
2024
Q1
$1.28M Sell
170,500
-112,400
-40% -$1.03M ﹤0.01% 1452
2023
Q4
$2.62M Sell
282,900
-36,300
-11% -$297K 0.01% 1130
2023
Q3
$3.23M Sell
319,200
-91,300
-22% -$1.09M 0.01% 939
2023
Q2
$5.13M Sell
410,500
-7,300
-2% -$86.9K 0.01% 769
2023
Q1
$4.88M Buy
417,800
+106,400
+34% +$1.36M 0.01% 819
2022
Q4
$3.31M Buy
311,400
+21,500
+7% +$208K 0.01% 960
2022
Q3
$2.81M Buy
289,900
+71,800
+33% +$951K 0.01% 1005
2022
Q2
$3.16M Buy
218,100
+189,100
+652% +$3.22M 0.01% 977
2022
Q1
$758K Buy
+29,000
New +$823K ﹤0.01% 1785
2021
Q2
Sell
-11,900
Closed -$557K 2545
2021
Q1
$557K Buy
+11,900
New +$576K ﹤0.01% 1969

Other funds holding HCAT

Two Sigma Advisers's HCAT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 31,100 shares — an estimated $74.3K sold.

Two Sigma Advisers first reported a position in HCAT in Q1 2021 and held it in 17 quarters. The position peaked at $5.13M in Q2 2023. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Two Sigma Advisers reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 31,100 Health Catalyst shares in Q1 2026, an estimated $74.3K.
  • Two Sigma Advisers first reported a position in Health Catalyst in Q1 2021 and held it in 17 quarters.
  • Two Sigma Advisers's Health Catalyst position peaked at $5.13M in Q2 2023.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.